FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Matthias Müller

Research Profile

Concepts & Ideas

Disorders

Chemicals & Drugs

Antipsychotic Agents

Procedures

Anatomy

Activities & Behaviors

Schizophrenic Psychology

Geographic Areas

Germany

Co-author Network

Publications

TOP 3
Elnaz Ostad Haji; Marie-Luise Rao; Gerd Laux; Klaus Mann; Matthias J Müller; Katja Boland; Aleksandra Dragicevic; Miriam Fric; Christoph Hiemke
Potential Cost-effectiveness of Therapeutic Drug Monitoring for Depressed Patients Treated With Citalopram.
N Dreimüller; K Boland; B Bondy; Aleksandra Dragicevic; Gerd Laux; Klaus Lieb; Wolfgang Maier; Matthias J Müller; Marie Luise Rao; Marcella Rietschel; Joachim Röschke; A Tadić; P Zill; Christoph Hiemke
The serotonin transporter promoter polymorphism (5-HTTLPR) affects the relation between antidepressant serum concentrations and effectiveness in major depression.
Andreas Fellgiebel; Edwin Kolodny; Dominik O Wolf; Matthias J Müller
Hippocampal atrophy as a surrogate of neuronal involvement in Fabry disease.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Matthias Müller (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Elnaz Ostad Haji; Marie-Luise Rao; Gerd Laux; Klaus Mann; Matthias J Müller; Katja Boland; Aleksandra Dragicevic; Miriam Fric; Christoph Hiemke
Potential Cost-effectiveness of Therapeutic Drug Monitoring for Depressed Patients Treated With Citalopram.
Therapeutic drug monitoring 2013;35(3):396-401.
2012: N Dreimüller; K Boland; B Bondy; Aleksandra Dragicevic; Gerd Laux; Klaus Lieb; Wolfgang Maier; Matthias J Müller; Marie Luise Rao; Marcella Rietschel; Joachim Röschke; A Tadić; P Zill; Christoph Hiemke
The serotonin transporter promoter polymorphism (5-HTTLPR) affects the relation between antidepressant serum concentrations and effectiveness in major depression.
Pharmacopsychiatry 2012;45(3):108-13.
2012: Andreas Fellgiebel; Edwin Kolodny; Dominik O Wolf; Matthias J Müller
Hippocampal atrophy as a surrogate of neuronal involvement in Fabry disease.
Journal of inherited metabolic disease 2012;35(2):363-7.
2011: Igor Yakushev; Paul Cumming; Alex Gerhard; Matthias J Müller; Ingrid Schermuly; Mathias Schreckenberger; Peter Stoeter; Andreas Fellgiebel
Functional implications of hippocampal degeneration in early Alzheimer's disease: a combined DTI and PET study.
European journal of nuclear medicine and molecular imaging 2011;38(12):2219-27.
2011: Igor Yakushev; Hans-Georg Buchholz; Alex Gerhard; Alexander Hammers; Markus Lorscheider; Matthias J Müller; Ingrid Schermuly; Mathias Schreckenberger; Peter Stoeter; Carsten Weibrich; Andreas Fellgiebel
Relationships between hippocampal microstructure, metabolism, and function in early Alzheimer's disease.
Brain structure & function 2011;216(3):219-26.
2011: Elnaz Ostad Haji; André Tadić; Stefanie Wagner; Aleksandra Dragicevic; Matthias J Müller; Katja Boland; Marie Luise Rao; Miriam Fric; Gerd Laux; Christoph Hiemke
Association between citalopram serum levels and clinical improvement of patients with major depression.
Journal of clinical psychopharmacology 2011;31(3):281-6.
2011: I Schermuly; Matthias J Müller; Kay-Maria Müller; Juliane Albrecht; I Keller; Igor Yakushev; Michael Beck; A Fellgiebel
Neuropsychiatric symptoms and brain structural alterations in Fabry disease.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2011;18(2):347-53.
2010: Igor Yakushev; Matthias J Müller; Markus Lorscheider; Ingrid Schermuly; Carsten Weibrich; Paulo R Dellani; Alexander Hammers; Peter Stoeter; Andreas Fellgiebel
Increased hippocampal head diffusivity predicts impaired episodic memory performance in early Alzheimer's disease.
Neuropsychologia 2010;48(5):1447-53.
2009: Andreas Fellgiebel; I Keller; D Marin; Matthias J Müller; I Schermuly; Igor Yakushev; Juliane Albrecht; H Bellhäuser; M Kinateder; Michael Beck; Peter Stoeter
Diagnostic utility of different MRI and MR angiography measures in Fabry disease.
Neurology 2009;72(1):63-8.
2008: Paulo R Dellani; Stefan Eder; Joachim Gawehn; Goran Vucurevic; Andreas Fellgiebel; Matthias J Müller; Heinz Schmidberger; Peter Stoeter; Peter Gutjahr
Late structural alterations of cerebral white matter in long-term survivors of childhood leukemia.
Journal of magnetic resonance imaging : JMRI 2008;27(6):1250-5.
2008: Armin Scheurich; Benno Schanz; Matthias J Müller; Andreas Fellgiebel
[Early interventional group therapy for patients with incipient Alzheimer disease and their relatives].
Psychotherapie, Psychosomatik, medizinische Psychologie 2008;58(6):246-52.
2008: André Tadić; Dan Rujescu; Matthias J Müller; Ralf Kohnen; Hans H Stassen; Armin Szegedi; Norbert Dahmen
Association analysis between variants of the interleukin-1beta and the interleukin-1 receptor antagonist gene and antidepressant treatment response in major depression.
Neuropsychiatric disease and treatment 2008;4(1):269-76.
2008: Armin Scheurich; Andreas Fellgiebel; I Schermuly; S Bauer; R Wölfges; Matthias J Müller
Experimental evidence for a motivational origin of cognitive impairment in major depression.
Psychological medicine 2008;38(2):237-46.
2008: Andreas Fellgiebel; Ingrid Schermuly; Alexander Gerhard; Isabel Keller; Juliane Albrecht; Carsten Weibrich; Matthias J Müller; Peter Stoeter
Functional relevant loss of long association fibre tracts integrity in early Alzheimer's disease.
Neuropsychologia 2008;46(6):1698-706.
2007: André Tadić; Dan Rujescu; Matthias J Müller; Ralf Kohnen; Hans H Stassen; Norbert Dahmen; Armin Szegedi
A monoamine oxidase B gene variant and short-term antidepressant treatment response.
Progress in neuro-psychopharmacology & biological psychiatry 2007;31(7):1370-7.
2007: Matthias J Müller; Boris Regenbogen; Sebastian Härtter; Franz-Xaver Eich; Christoph Hiemke
Therapeutic drug monitoring for optimizing amisulpride therapy in patients with schizophrenia.
Journal of psychiatric research 2007;41(8):673-9.
2007: Juliane Albrecht; Paulo R Dellani; Matthias J Müller; I Schermuly; Michael Beck; Peter Stoeter; A Gerhard; Andreas Fellgiebel
Voxel based analyses of diffusion tensor imaging in Fabry disease.
Journal of neurology, neurosurgery, and psychiatry 2007;78(9):964-9.
2007: Andreas Fellgiebel; Armin Scheurich; Peter Bartenstein; Matthias J Müller
FDG-PET and CSF phospho-tau for prediction of cognitive decline in mild cognitive impairment.
Psychiatry research 2007;155(2):167-71.
2007: Matthias J Müller
Gender-specific associations of depression with positive and negative symptoms in acute schizophrenia.
Progress in neuro-psychopharmacology & biological psychiatry 2007;31(5):1095-100.
2007: André Tadić; Matthias J Müller; Dan Rujescu; Ralf Kohnen; Hans H Stassen; Norbert Dahmen; Armin Szegedi
The MAOA T941G polymorphism and short-term treatment response to mirtazapine and paroxetine in major depression.
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2007;144B(3):325-31.
2007: Andreas Fellgiebel; Juliane Albrecht; Paulo R Dellani; Ingrid Schermuly; Peter Stoeter; Matthias J Müller
Quantification of brain tissue alterations in Fabry disease using diffusion-tensor imaging.
Acta paediatrica (Oslo, Norway : 1992). Supplement 2007;96(455):33-6.
2007: Matthias J Müller; Dirk Greverus; Carsten Weibrich; Paulo R Dellani; Armin Scheurich; Peter Stoeter; Andreas Fellgiebel
Diagnostic utility of hippocampal size and mean diffusivity in amnestic MCI.
Neurobiology of aging 2007;28(3):398-403.
2007: Andreas Fellgiebel; Matthias J Müller; Christoph Hiemke; Peter Bartenstein; Matthias Schreckenberger
Clinical improvement in a case of frontotemporal dementia under aripiprazole treatment corresponds to partial recovery of disturbed frontal glucose metabolism.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2007;8(2):123-6.
2006: M Nill; Matthias J Müller; Michael Beck; Peter Stoeter; Andreas Fellgiebel
[Pathophysiological aspects of brain structural disturbances in patients with Fabry disease: literature review].
Fortschritte der Neurologie-Psychiatrie 2006;74(12):687-95.
2006: Mohamed EL Houseiny El Sebeay Shams; B Arneth; Christoph Hiemke; Aleksandra Dragicevic; Matthias J Müller; R Kaiser; K Lackner; Sebastian Härtter
CYP2D6 polymorphism and clinical effect of the antidepressant venlafaxine.
Journal of clinical pharmacy and therapeutics 2006;31(5):493-502.
2006: Andreas Fellgiebel; Matthias J Müller; Lionel Ginsberg
CNS manifestations of Fabry's disease.
Lancet neurology 2006;5(9):791-5.
2006: Matthias J Müller; Andreas Fellgiebel; Armin Scheurich; Catharina Whybra; Michael Beck; Kay-Maria Müller
Recurrent brief depression in a female patient with Fabry disease.
Bipolar disorders 2006;8(4):418-9.
2006: Andreas Fellgiebel; Martin Mazanek; Catharina Whybra; Michael Beck; Ralf Hartung; Kay-Maria Müller; Armin Scheurich; Paulo R Dellani; Peter Stoeter; Matthias J Müller
Pattern of microstructural brain tissue alterations in Fabry disease: a diffusion-tensor imaging study.
Journal of neurology 2006;253(6):780-7.
2006: Matthias J Müller; Kay-Maria Müller; Andreas Fellgiebel
Detection of depression in acute schizophrenia: sensitivity and specificity of 2 standard observer rating scales.
Canadian journal of psychiatry. Revue canadienne de psychiatrie 2006;51(6):387-92.
2006: Ingo Vernaleken; Yoshitaka Kumakura; Paul Cumming; Hans-Georg Buchholz; Thomas Siessmeier; Peter Stoeter; Matthias J Müller; Peter Bartenstein; Gerhard Gründer
Modulation of [18F]fluorodopa (FDOPA) kinetics in the brain of healthy volunteers after acute haloperidol challenge.
NeuroImage 2006;30(4):1332-9.
2006: Andreas Fellgiebel; Paulo R Dellani; Dirk Greverus; Armin Scheurich; Peter Stoeter; Matthias J Müller
Predicting conversion to dementia in mild cognitive impairment by volumetric and diffusivity measurements of the hippocampus.
Psychiatry research 2006;146(3):283-7.
2006: Matthias J Müller; B Regenbogen; Julia Sachse; Franz-Xaver Eich; Sebastian Härtter; Christoph Hiemke
Gender aspects in the clinical treatment of schizophrenic inpatients with amisulpride: a therapeutic drug monitoring study.
Pharmacopsychiatry 2006;39(2):41-6.
2006: Matthias J Müller; Martin Mazanek; Carsten Weibrich; Paulo R Dellani; Peter Stoeter; Andreas Fellgiebel
Distribution characteristics, reproducibility, and precision of region of interest-based hippocampal diffusion tensor imaging measures.
AJNR. American journal of neuroradiology 2006;27(2):440-6.
2006: Klaus Mann; Wolfgang Rossbach; Matthias J Müller; Florian Müller-Siecheneder; Tobias Pott; Iris Linde; Ralf W Dittmann; Christoph Hiemke
Nocturnal hormone profiles in patients with schizophrenia treated with olanzapine.
Psychoneuroendocrinology 2006;31(2):256-64.
2005: Matthias J Müller; Dirk Greverus; Paulo R Dellani; Carsten Weibrich; Paulo R Wille; Armin Scheurich; Peter Stoeter; Andreas Fellgiebel
Functional implications of hippocampal volume and diffusivity in mild cognitive impairment.
NeuroImage 2005;28(4):1033-42.
2005: Matthias J Müller; Kay-Maria Müller; A Dascalescu; Catharina Whybra; Karin Baron; Armin Scheurich; K Mann; Michael Beck; Lutz G Schmidt; Andreas Fellgiebel
[Psychiatric and neuropsychological signs and symptoms in patients with fabry disease: literature review].
Fortschritte der Neurologie-Psychiatrie 2005;73(11):687-93.
2005: Katrin M Kirschbaum; Matthias J Müller; Gerald Zernig; Alois Saria; Arian Mobascher; Jaroslav Malevani; Christoph Hiemke
Therapeutic monitoring of aripiprazole by HPLC with column-switching and spectrophotometric detection.
Clinical chemistry 2005;51(9):1718-21.
2005: Matthias J Müller; Helena Brening; Christoph Gensch; Jochen Klinga; Barbara Kienzle; Kay-Maria Müller
The Calgary Depression Rating Scale for schizophrenia in a healthy control group: psychometric properties and reference values.
Journal of affective disorders 2005;88(1):69-74.
2005: Andreas Fellgiebel; Matthias J Müller; Martin Mazanek; Karin Baron; Michael Beck; Peter Stoeter
White matter lesion severity in male and female patients with Fabry disease.
Neurology 2005;65(4):600-2.
2005: Andreas Fellgiebel; Matthias J Müller; Paulo R Wille; Paulo R Dellani; Armin Scheurich; Lutz G Schmidt; Peter Stoeter
Color-coded diffusion-tensor-imaging of posterior cingulate fiber tracts in mild cognitive impairment.
Neurobiology of aging 2005;26(8):1193-8.
2005: Matthias J Müller; Armin Scheurich; Hermann Wetzel; Armin Szegedi; Martin Hautzinger
Sequentially adjusted randomization to force balance in controlled trials with unknown prevalence of covariates: application to alcoholism research.
Alcohol and alcoholism (Oxford, Oxfordshire) 2005;40(2):124-31.
2005: Martin Hautzinger; Hermann Wetzel; Armin Szegedi; Armin Scheurich; Bernd Lörch; P Singer; D Schläfke; Helmut Sittinger; Thomas Wobrock; Matthias J Müller; I Anghelescu
[Combination treatment with SSRI and cognitive behavior therapy for relapse prevention of alcohol-dependent men. Results of a randomized, controlled multicenter therapeutic study].
Der Nervenarzt 2005;76(3):295-307.
2005: Armin Scheurich; Matthias J Müller; Ion Anghelescu; Bernd Lörch; M Dreher; Martin Hautzinger; Armin Szegedi
Reliability and validity of the form 90 interview.
European addiction research 2005;11(1):50-6.
2005: Armin Szegedi; Dan Rujescu; André Tadic; Matthias J Müller; Ralf Kohnen; Hans H Stassen; Norbert Dahmen
The catechol-O-methyltransferase Val108/158Met polymorphism affects short-term treatment response to mirtazapine, but not to paroxetine in major depression.
The pharmacogenomics journal 2005;5(1):49-53.
2004: Klaus Mann; Wolfgang Rossbach; Matthias J Müller; Florian Müller-Siecheneder; Hagen Ru; Ralf W Dittmann
Heart rate variability during sleep in patients with schizophrenia treated with olanzapine.
International clinical psychopharmacology 2004;19(6):325-30.
2004: Hermann Wetzel; Armin Szegedi; Armin Scheurich; Bernd Lörch; Peter Singer; Detlef Schläfke; Helmut Sittinger; Thomas Wobrock; Matthias J Müller; Ion Anghelescu; Martin Hautzinger
Combination treatment with nefazodone and cognitive-behavioral therapy for relapse prevention in alcohol-dependent men: a randomized controlled study.
The Journal of clinical psychiatry 2004;65(10):1406-13.
2004: Andreas Fellgiebel; Thomas Siessmeier; Armin Scheurich; Georg Winterer; Peter Bartenstein; Lutz G Schmidt; Matthias J Müller
Association of elevated phospho-tau levels with Alzheimer-typical 18F-fluoro-2-deoxy-D-glucose positron emission tomography findings in patients with mild cognitive impairment.
Biological psychiatry 2004;56(4):279-83.
2004: Matthias J Müller; Wolfgang Rossbach; Klaus Mann; Joachim Röschke; Florian Müller-Siecheneder; M Blümler; Hermann Wetzel; H Russ; Ralf W Dittmann; Otto Benkert
Subchronic effects of olanzapine on sleep EEG in schizophrenic patients with predominantly negative symptoms.
Pharmacopsychiatry 2004;37(4):157-62.
2004: Christoph Hiemke; Aleksandra Dragicevic; Gerhard Gründer; Sebastian Hätter; Julia Sachse; Ingo Vernaleken; Matthias J Müller
Therapeutic monitoring of new antipsychotic drugs.
Therapeutic drug monitoring 2004;26(2):156-60.
2004: Armin Scheurich; Matthias J Müller; Armin Szegedi; Ion Anghelescu; Christoph Klawe; Bernd Lörch; Bernd Kappis; H-G Bialonski; S Haas; Martin Hautzinger
Neuropsychological status of alcohol-dependent patients: increased performance through goal-setting instructions.
Alcohol and alcoholism (Oxford, Oxfordshire) 2004;39(2):119-25.
2004: Andreas Fellgiebel; Paulo R Wille; Matthias J Müller; Georg Winterer; Armin Scheurich; Goran Vucurevic; Lutz G Schmidt; Peter Stoeter
Ultrastructural hippocampal and white matter alterations in mild cognitive impairment: a diffusion tensor imaging study.
Dementia and geriatric cognitive disorders 2004;18(1):101-8.
2003: Matthias J Müller; Hubertus Himmerich; Barbara Kienzle; Armin Szegedi
Differentiating moderate and severe depression using the Montgomery-Asberg depression rating scale (MADRS).
Journal of affective disorders 2003;77(3):255-60.
2003: Hubertus Himmerich; Armin Szegedi; Christoph Klawe; Ion Anghelescu; Matthias J Müller
Distigmine bromide induced acute psychotic disorder in a patient with multiple sclerosis.
European psychiatry : the journal of the Association of European Psychiatrists 2003;18(6):318-9.
2003: Matthias J Müller; Aleksandra Dragicevic
Standardized rater training for the Hamilton Depression Rating Scale (HAMD-17) in psychiatric novices.
Journal of affective disorders 2003;77(1):65-9.
2003: Matthias J Müller; Aleksandra Dragicevic; Mirijam Fric; I Gaertner; Katja Grasmäder; Sebastian Härtter; E Hermann; Hans-Joachim Kuss; Gerd Laux; W Oehl; Marie Luise Rao; N Rollmann; Harald Weigmann; M Weber-Labonte; Christoph Hiemke
Therapeutic drug monitoring of tricyclic antidepressants: how does it work under clinical conditions?
Pharmacopsychiatry 2003;36(3):98-104.
2003: Armin Szegedi; Matthias J Müller; Ion Anghelescu; Christoph Klawe; Ralf Kohnen; Otto Benkert
Early improvement under mirtazapine and paroxetine predicts later stable response and remission with high sensitivity in patients with major depression.
The Journal of clinical psychiatry 2003;64(4):413-20.
2003: Gerhard Gründer; Ingo Vernaleken; Matthias J Müller; Eugen Davids; Nilufar Heydari; Hans-Georg Buchholz; Peter Bartenstein; Ole Lajord Munk; Peter Stoeter; Dean F Wong; Albert Gjedde; Paul Cumming
Subchronic haloperidol downregulates dopamine synthesis capacity in the brain of schizophrenic patients in vivo.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2003;28(4):787-94.
2003: Karl Mann; Matthias J Müller; C Hiemke; Otto Benkert
[Standardized documentation procedure as a basis for improvement of process quality of treatment in psychiatric hospitals].
Der Nervenarzt 2003;74(3):235-44.
2003: Michael Grözinger; Aleksandra Dragicevic; Christoph Hiemke; Mohamed EL Houseiny El Sebeay Shams; Matthias J Müller; Sebastian Härtter
Melperone is an inhibitor of the CYP2D6 catalyzed O-demethylation of venlafaxine.
Pharmacopsychiatry 2003;36(1):3-6.
2003: Christian Lange-Asschenfeldt; Matthias J Müller; Armin Szegedi; Ion Anghelescu; Christoph Klawe; Hermann Wetzel
Symptom-triggered versus standard chlormethiazole treatment of inpatient alcohol withdrawal: clinical implications from a chart analysis.
European addiction research 2003;9(1):1-7.
2002: Matthias J Müller; Hermann Wetzel; Franz-Xaver Eich; Werner Rein; Alain Puech; Otto Benkert
Dose-related effects of amisulpride on five dimensions of psychopathology in patients with acute exacerbation of schizophrenia.
Journal of clinical psychopharmacology 2002;22(6):554-60.
2002: Matthias J Müller; Barbara Kienzle; Norbert Dahmen
Depression, emotional blunting, and akinesia in schizophrenia. Overlap and differentiation.
The European journal of health economics : HEPAC : health economics in prevention and care 2002;3 Suppl 2():S99-103.
2002: Norbert Dahmen; Meike Kasten; K Mittag; Matthias J Müller
Narcoleptic and schizophrenic hallucinations. Implications for differential diagnosis and pathophysiology.
The European journal of health economics : HEPAC : health economics in prevention and care 2002;3 Suppl 2():S94-8.
2002: Eugen Davids; Matthias J Müller; Nicole Rollmann; Martin Burkart; Eva Regier-Klein; Armin Szegedi; Otto Benkert; Wolgang Maier
Syndrome profiles in alcoholism and panic disorder with or without agoraphobia: an explorative family study.
Progress in neuro-psychopharmacology & biological psychiatry 2002;26(6):1079-87.
2002: Matthias J Müller; Hermann Wetzel; Otto Benkert
Differential effects of high-dose amisulpride versus flupentixol on latent dimensions of depressive and negative symptomatology in acute schizophrenia: an evaluation using confirmatory factor analysis.
International clinical psychopharmacology 2002;17(5):249-61.
2002: Norbert Dahmen; Meike Kasten; Matthias J Müller; Karla Mittag
Frequency and dependence on body posture of hallucinations and sleep paralysis in a community sample.
Journal of sleep research 2002;11(2):179-80.
2002: Matthias J Müller; Armin Szegedi
Effects of interrater reliability of psychopathologic assessment on power and sample size calculations in clinical trials.
Journal of clinical psychopharmacology 2002;22(3):318-25.
2002: Matthias J Müller; Ralf Schlösser; Gisela Kapp-Steen; Benno Schanz; Otto Benkert
Patients' satisfaction with psychiatric treatment: comparison between an open and a closed ward.
The Psychiatric quarterly 2002;73(2):93-107.
2001: Matthias J Müller; Otto Benkert
Lower self-reported depression in patients with erectile dysfunction after treatment with sildenafil.
Journal of affective disorders 2001;66(2-3):255-61.
2001: Ion Anghelescu; Sabine Germeyer; Matthias J Müller; Christoph Klawe; Peter Singer; Norbert Dahmen; Hermann Wetzel; Hubertus Himmerich; Armin Szegedi
No association between the dopamine d2 receptor taqi a1 allele and earlier age of onset of alcohol dependence according to different specified criteria.
Alcoholism, clinical and experimental research 2001;25(6):805-9.
2001: Matthias J Müller; J Ruof; M Graf-Morgenstern; H Porst; Otto Benkert
Quality of partnership in patients with erectile dysfunction after sildenafil treatment.
Pharmacopsychiatry 2001;34(3):91-5.
2001: Norbert Dahmen; Matthias J Müller; Sabine Germeyer; Dan Rujescu; I Anghelescu; Christoph Hiemke; Hermann Wetzel
Genetic polymorphisms of the dopamine D2 and D3 receptor and neuroleptic drug effects in schizophrenic patients.
Schizophrenia research 2001;49(1-2):223-5.
2001: Matthias J Müller; Sebastian Härtter; D Köhler; Christoph Hiemke
Serum levels of sulpiride enantiomers after oral treatment with racemic sulpiride in psychiatric patients: a pilot study.
Pharmacopsychiatry 2001;34(1):27-32.
2000: Armin Scheurich; Matthias J Müller; Hermann Wetzel; Ion Anghelescu; Christoph Klawe; A Ruppe; Bernd Lörch; Hubertus Himmerich; M Heidenreich; G Schmid; Martin Hautzinger; Armin Szegedi
Reliability and validity of the German version of the European Addiction Severity Index (EuropASI).
Journal of studies on alcohol 2000;61(6):916-9.
2000: Matthias J Müller; Armin Szegedi; Hermann Wetzel; Otto Benkert
Moderate and severe depression. Gradations for the Montgomery-Asberg Depression Rating Scale.
Journal of affective disorders 2000;60(2):137-40.
2000: Armin Szegedi; Matthias J Müller; Hubertus Himmerich; Ion Anghelescu; Hermann Wetzel
Carbohydrate-deficient transferrin (CDT) and HDL cholesterol (HDL) are highly correlated in male alcohol dependent patients.
Alcoholism, clinical and experimental research 2000;24(4):497-500.
2000: Matthias J Müller; Wolfgang Rossbach; Eugen Davids; Hermann Wetzel; Otto Benkert
[Evaluation of standardized training for the "Positive and Negative Syndrome Scale" (PANSS)].
Der Nervenarzt 2000;71(3):195-204.
2000: Joachim Röschke; C Wolf; Matthias J Müller; Peter Wagner; K Mann; Michael Grözinger; S Bech
The benefit from whole body acupuncture in major depression.
Journal of affective disorders 2000;57(1-3):73-81.
1999: Matthias J Müller; Gerhard Gründer; Hermann Wetzel; Florian Müller-Siecheneder; P Marx-Dannigkeit; Otto Benkert
Antipsychotic effects and tolerability of the sigma ligand EMD 57445 (panamesine) and its metabolites in acute schizophrenia: an open clinical trial.
Psychiatry research 1999;89(3):275-80.
1999: Matthias J Müller; P Marx-Dannigkeit; Ralf Schlösser; Hermann Wetzel; D Addington; Otto Benkert
The Calgary Depression Rating Scale for Schizophrenia: development and interrater reliability of a German version (CDSS-G).
Journal of psychiatric research 1999;33(5):433-43.
1999: Gerhard Gründer; Matthias J Müller; J Andreas; N Heydari; Hermann Wetzel; Ralf Schlösser; S Schlegel; Otmar Nickel; D Eissner; Otto Benkert
Occupancy of striatal D(2)-like dopamine receptors after treatment with the sigma ligand EMD 57445, a putative atypical antipsychotic.
Psychopharmacology 1999;146(1):81-6.
1999: Matthias J Müller; Eugen Davids
Relationship of psychiatric experience and interrater reliability in assessment of negative symptoms.
The Journal of nervous and mental disease 1999;187(5):316-8.
1998: Armin Szegedi; Ion Anghelescu; T Pauly; Norbert Dahmen; Matthias J Müller; Hermann Wetzel; Christoph Hiemke
Activity of the adenylyl cyclase in lymphocytes of male alcoholic patients is state dependent.
Alcoholism, clinical and experimental research 1998;22(9):2073-9.
1998: Matthias J Müller; Hermann Wetzel
Dimensionality of depression in acute schizophrenia: a methodological study using the Bech-Rafaelsen Melancholia Scale (BRMES).
Journal of psychiatric research 1998;32(6):369-78.
1998: Matthias J Müller; Wolfgang Rossbach; P Dannigkeit; Florian Müller-Siecheneder; Armin Szegedi; Hermann Wetzel
Evaluation of standardized rater training for the Positive and Negative Syndrome Scale (PANSS).
Schizophrenia research 1998;32(3):151-60.
1998: Florian Müller-Siecheneder; Matthias J Müller; A Hillert; Armin Szegedi; Hermann Wetzel; Otto Benkert
Risperidone versus haloperidol and amitriptyline in the treatment of patients with a combined psychotic and depressive syndrome.
Journal of clinical psychopharmacology 1998;18(2):111-20.